Medtronic (MDT) terminates deal to acquire EOFlow

Medtronic (NYSE: MDT) said on December 6, 2023, based upon multiple breaches under the Agreements, it delivered notice to EOFlow that it had exercised its right to terminate the Agreements. Medtronic does not believe any termination fee is payable under the Agreements. The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.

You May Also Be Interested In

• Holcim to acquire Fermacell from James Hardie for EUR 840M
• FS Bancorp completes acquisition of Pacific West Bancorp
• Etsy upgraded to buy at BofA on durable growth, buyback potential